Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease

M. Tibiletti (Manchester, United Kingdom), J. Naish (Manchester, United Kingdom), M. Heaton (Manchester, United Kingdom), J. Waterton (Manchester, United Kingdom), P. Hughes (Sheffield, United Kingdom), J. Eaden (Sheffield, United Kingdom), S. Skeoch (Bath, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), I. Bruce (Manchester, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), G. Parker (Manchester, United Kingdom)

Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Session: Quantitative imaging in diffuse lung disease
Session type: Oral Presentation
Number: 4330
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Tibiletti (Manchester, United Kingdom), J. Naish (Manchester, United Kingdom), M. Heaton (Manchester, United Kingdom), J. Waterton (Manchester, United Kingdom), P. Hughes (Sheffield, United Kingdom), J. Eaden (Sheffield, United Kingdom), S. Skeoch (Bath, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), I. Bruce (Manchester, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), G. Parker (Manchester, United Kingdom). Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease. 4330

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Novel imaging biomarkers for assessment of lung fibrosis and inflammation
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021


Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016



CT and interstitial lung disease
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018


Role of imaging in progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180073; 10.1183/16000617.0073-2018
Year: 2018



Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study
Source: Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020
Year: 2021



Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001

3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009



Ultrasound in the assessment of interstitial lung diseases: Correlation with high-resolution computed tomography and lung functions
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension.
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Isolated reduction in residual volume on body plethysmography is an early indicator of parenchymal lung disease
Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Year: 2016


Roles of transthoracic lung ultrasonography in diagnosis of interstitial lung disease: correlation with  HRCT, vital capacity, diffusing of the lung for monoxide test
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

Correlation between volumetric CT scans and lung function in lower respiratory tract infection
Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings
Year: 2013